亚洲 · 区域市场 · Business Standard
Alembic Pharma shares hit 20% upper circuit after 81% YoY rise in Q2 PAT
Alembic Pharma's revenue from operations increased by 36 per cent YoY to ₹2,603 crore during the said period from ₹1,910 crore a year ago.
在 Business Standard 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.business-standard.com)
